Try our Advanced Search for more refined results

Expert Analysis

The 'Newly Acquired Information' Shift In Pharma Litigation

By Richard Dean (June 10, 2019, 3:30 PM EDT) -- There has been a sea change in pharmaceutical litigation over the last four years. Before 2015, the key issue on which most pharmaceutical litigation generally turned was the adequacy of the warning given the prescribing physician; litigation was characterized by testimony about the physician's subjective knowledge of drug-related risks, experience with the drug in question and prescribing habits....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!